Abstract
Stereotactic body radiation therapy (SBRT) has been increasingly used in the treatment of early-stage NSCLC, especially for patients who cannot undergo surgery. Compared with other imaging modalities, PET/CT has higher sensitivity and specificity in diagnosis and staging of NSCLC as well as higher prediction value for prognosis. The progress of 18F-FDG PET/CT in evaluation of the therapeutic response and prognosis after SBRT for early-stage NSCLC is summarized in this review. Key words: Radiotherapy; Carcinoma, non-small-cell lung; Tomography, emission-computed; Tomography, X-ray computed; Trends
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call